best glp-1 agonists for weight loss How medications are transforming diabetes and treatment The New Weight Management Meds

Race and ethnicity Relatively few RCTs have conducted formal subgroup analyses by race or ethnicity, and available data are limited by underrepresentation of non-White participants

Relative to comparators, the risk for any of the commonly used cardiovascular end points was estimated to be below 1.0, and for both MACE-4 and MACE-3 (myocardial infarction, stroke, and all-cause death), the upper bounds of the confidence interval calculated around the hazard ratio were decidedly 8.5 %

David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University Kiet Ngo, Pharm D Candidate Mercer University Abnormalities in incretin hormones such as the glucagon-like peptide-1 (GLP-1) contribute to the development of hyperglycemia

Investigation of the Haemodynamic Effects of Exenatide in Healthy Male Subjects

Jiang H, Pang S, Zhang Y, Yu T, Liu M, Deng H, et al